Beyond Air
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
900 Stewart Ave Ste 301, Garden City, Ne...Phone Number
(516) 665-8200Website
www.beyondair.netRevenue
$7.7 MillionStock Symbol
XAIRIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Beyond Air
Founded in 2011 and headquartered in Garden City, New York, Beyond Air is a medical device and biopharmaceutical company dedicated to harnessing the power of nitric oxide (NO) through its revolutionary NO Generator and Delivery System, LungFit, that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases.Explore more
Beyond Air Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Beyond Air your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Beyond Air recently announced quarterly report
Check if Beyond Air has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Beyond Air
Check out if Beyond Air is spiking on competitors!
Website visits: Recent activity has been detected on your website
Beyond Air, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Beyond Air has new funding data
Product Launch: Get notified when Beyond Air launches new products
Click to see if Beyond Air had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Beyond Air
Find 2 more new buyers
Compare Similar Companies to Beyond Air
Compare insights from companies similar to Beyond Air, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Beyond Air is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Beyond Air is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Beyond Air.
Beyond Air financials insights
Gather financial insights about Beyond Air, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$30M
2023
Debt
$40M
2024
Share Placement
$20.6M
2025
Debt
$32M
2026
Stock/Share Issuance
$10.2M
Beyond Air Tech Stack
A closer look at the technologies used by Beyond Air
Most Recent Scoops
Earnings
Beyond Air has reported R&D expenses of $10.2 million for fiscal year 2026, a decrease of 39% compared to $16.9 million for fiscal year 2025, primarily driven by lower employee expenses from prior restructuring activities and reduced development costs associated with its Gen 2 device.
Spending/Investment, Research & Development
Pain Point
Beyond Air is facing a NASDAQ minimum bid price compliance requirement, with the NASDAQ hearings panel granting the company's request to continue listing subject to regaining compliance by July 31, 2026. Following stockholder approval on June 18, the company's board approved a 1-for-20 reverse stock split, which the company expects will enable it to meet the compliance deadline.
Compliance, Stake & Stock Ownership, Finance
Earnings
Beyond Air has reported a gross profit of $300,000 for fiscal year 2026, compared to a gross loss of $1.7 million for fiscal year 2025, representing a $2 million improvement driven by operating leverage as revenue scales.
Earnings, Finance
Earnings
Beyond Air has reported SG&A expenses of $19.1 million for fiscal year 2026, a decrease of 27% compared to $26 million for fiscal year 2025, primarily driven by lower employee-related costs resulting from prior restructuring initiatives.
Earnings, Spending/Investment, Finance
Project
Product Development
Beyond Air News & Media
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript
FDA approval decision looms for next-gen device as revenue guidance projects 110% growth.Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m.Beyond Air (NASDAQ: XAIR) prices $10.2M private placement with warrant upside
Upfront $10.2M financing could reach $30.1M for Beyond Air through pre-funded, Series A and Series B warrants, funding working capital and LungFit PH II plans.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Beyond Air
Sign Up For FreeTo access detailed company insights
Founded in 2011 and headquartered in Garden City, New York, Beyond Air is a medical device and biopharmaceutical company dedicated to harnessing the power of nitric oxide (NO) through its revolutionary NO Generator and Delivery System, LungFit, that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential t... Read More
